Watch the full video on YouTube to explore how EASD develops clinical guidance and how it shapes diabetes care worldwide.

In this episode, members of the EASD Committee on Clinical Affairs (CCA) discuss:

Explore the speakers’ profiles:

EASD members are encouraged to propose new topics for clinical guidance. Suggestions can be submitted via the EASD Office at the start of the development process.

For more episodes, visit our podcast archive

Watch the full video on YouTube to explore expert insights on nutrition, weight loss, and type 2 diabetes remission.

In this episode, Prof. Nita Forouhi (University of Cambridge) and Prof. Michael Lean (University of Glasgow) discuss:

Explore related EASD sessions and view our speakers’ profiles:

For more expert discussions, visit our podcast archive.

Watch the full video on YouTube to explore expert perspectives on severe hypoglycaemia in type 1 diabetes and the evolving role of technology, transplantation and psychological support.

In this episode, our expert panel discusses:

Explore related session from the EASD Annual Meeting and view our speakers’ profiles:

For more expert conversations, visit our podcast archive

Watch the full video on YouTube to explore the evolving evidence linking diabetes and dementia, and how prevention strategies may reshape long-term outcomes.

In this episode, Prof. Gill Livingston (Unioversity College London) and Prof. Thomas van Sloten (UMC Utrecht) discuss:

This episode highlights a major shift: brain health is now central to long-term diabetes care.

Explore the related session from the EASD 2025 Annual Meeting and view our speakers’ profiles:

For more expert conversations, visit our podcast archive.

Watch the full episode on YouTube to hear Prof. Francesco Giorgino (EASD President) and Prof. Leszek Czupryniak (EASD Global Council Advisor) introduce EASD's newest initiative: the Global Council, launched in Madrid in 2023. This 13-member council brings together diabetes experts from Asia, North and South America, Africa, the Middle East, Australia, and underrepresented regions of Europe to provide direct, active contributions to EASD activities and address global challenges in diabetes research and care. The council's first major achievement is a comprehensive paper published in Diabetologia that identifies global challenges for diabetes research, care, and organizations from a unique perspective - starting from research but extending into practical care delivery. Learn how experts from every continent are working together to address global challenges, promote equity, and celebrate excellence in diabetes research.

The episode also announces a historic milestone: EASD's first new prize in nearly 60 years - the inaugural Global Impact Prize for Diabetes awarded to Dr. Viswanathan Mohan from India for pioneering work in diabetes epidemiology and subtypes in Asia in 2025 - a testament to the importance of global perspectives in diabetes research.

Looking forward, the council is developing global structures for registries, supporting research development in underserved regions, and moving from hopes to concrete solutions

Explore the EASD 2025 Global Impact Prize Lecture in Vienna and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

In this episode, a cardiologist (Dr. Kieran Docherty), an epidemiologist (Dr. Paul Welsh) and a diabetologist (Dr. Hertzel C. Gerstein) discuss the growing overlap between diabetes and cardiovascular disease and why collaboration across specialties is essential for patient care. Watch the full episode on YouTube to learn more about how collaboration across disciplines is shaping the future of diabetes and cardiovascular medicine.

Topics discussed include:

🎥 Explore the related full EASD-ESC Joint Symposium session and learn more about our expert speakers via the EASD Media Centre:

🎧 Discover previous episodes of Diabetes Insights in our podcast archive.

Watch the full episode on YouTube to explore how circadian rhythms, meal timing, and exercise interact with metabolism and diabetes risk. Prof. Frédéric Gachon and Prof. Olga Pivovarova-Ramich discuss why _when _we eat matters, how chronotype influences insulin sensitivity and body weight, and what current evidence tells us about intermittent fasting and time-restricted eating.

Topics include:

Explore the EASD 2025 Annual Meeting session and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

Watch the full episode on YouTube or listen on your preferred podcast platform to explore the SURPASS-CVOT trial results. In this episode, EASD TV Host, Vivienne Parry sits with Prof. Tina Vilsbøll (EASD Honorary Secretary) and Prof. Hertzel Gerstein (EASD Independent Advisor and McMaster University) as they explain how tirzepatide performs compared to dulaglutide in cardioprotective outcomes. The experts unpack the trial’s implications for clinical practice, highlighting how outcomes trials like this inform personalised medicine, integrate care between diabetologists and cardiologists, and generate new hypotheses in areas such as liver disease, cognitive function, and obesity management

Learn more about the trial and its relevance for clinical practice, multi-specialist care, and future research directions, including the integration of cardiovascular, liver, and cognitive outcomes into comprehensive diabetes management.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

Watch the full video on YouTube to hear Prof. Hindrik Mulder, editor-in-chief of Diabetologia, reflect on the scientific clinical and societal forces shaping the future of diabetes research.

In this episode, we explore:

Start the year with insights from the editor's desk and discover what's next in diabetes research.

Explore Prof. Mulder's profile and the Diabetologia Symposium from the EASD Annual Meeting 2025:

For more conversations with leading voices in diabetes research, visit our podcast archive

Watch the full video on YouTube to learn more about the SURPASS-PEDS trial and the first use of a dual GIP/GLP-1 agonist in adolescents with type 2 diabetes. Explore background research on youth-onset type 2 diabetes, including rising incidence, weight-gain velocity, and metabolic progression.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.